At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.

This Is Living With Cancer™ is a program designed for those who have been affected by cancer and those who love them. This program is available to anyone in the United States, regardless of age, income, race, location, cancer type or stage of disease. Anyone can use this program, whether they're currently on a Pfizer Oncology treatment or not.